Close Menu
Home › Evotec, Indivumed Partner on Colorectal Cancer Drug Discovery

Evotec, Indivumed Partner on Colorectal Cancer Drug Discovery

Apr 11, 2019
|
staff reporter

NEW YORK (GenomeWeb) — Evotec and Indivumed announced today that they have partnered to discover and develop new precision therapeutics for colorectal cancer.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Nov
18
Featured Webinar

Simultaneous Single-Cell DNA and Protein Sequencing in AML Samples

Sponsored by
Mission Bio

This webinar will outline the results of a study that performed integrative single-cell genome and cell surface protein expression profiling of adult acute myeloid leukemia (AML) cases. 

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Cancer

  1. FDA Clears NantHealth Tumor-Normal Whole-Exome Test

  2. AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions

    Premium

  3. Bristol-Myers, PathAI Show Artificial Intelligence Is on Par With Manual PD-L1 Scoring

    Premium

  4. Colorectal Cancers Dial up Mutability in Response to Targeted Treatments

  5. NSGC Panel Divided on Whether Newly Diagnosed Breast Cancer Patients Should Undergo Panel Testing

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.